Caricamento...

Current advances in biomarkers for targeted therapy in triple-negative breast cancer

Triple-negative breast cancer (TNBC) is a complex heterogeneous disease characterized by the absence of three hallmark receptors: human epidermal growth factor receptor 2, estrogen receptor, and progesterone receptor. Compared to other breast cancer subtypes, TNBC is more aggressive, has a higher pr...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Breast Cancer (Dove Med Press)
Autori principali: Fleisher, Brett, Clarke, Charlotte, Ait-Oudhia, Sihem
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2016
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5063595/
https://ncbi.nlm.nih.gov/pubmed/27785100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S114659
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !